Literature DB >> 9184106

Hyperplastic changes within the leptomeninges of the rat and monkey in response to chronic intracerebroventricular infusion of nerve growth factor.

P A Day-Lollini1, G R Stewart, M J Taylor, R M Johnson, G J Chellman.   

Abstract

Recombinant human nerve growth factor (rhNGF) was delivered for up to 6 months by continuous intracerebroventricular (i.c.v.) infusion to CD (Sprague-Dawley derived) rats and cynomolgus monkeys. Rats (n = 15/sex/group) received doses of 0 (vehicle), 6, 60, or 300 ng/day; monkeys (n = 5/sex/group) received 0, 0.6, 6, or 60 microg/day of rhNGF. Animals tolerated i.c.v. infusion with no behavioral signs attributable to rhNGF. Body weight was transiently decreased in female rats at the highest dose. At the completion of dosing, histological examination in both species revealed an increase in the thickness of the leptomeninges along the ventral and lateral surfaces of the hindbrain and extending over the dorsal aspect of the spinal cord. The change was present to varying degrees at all doses of rhNGF and tended to be more severe at higher doses. At the light microscopic level, the leptomeninges contained layers of well-differentiated, spindle-shaped cells and a plexus of axonal fibers. Cells were immunoreactive for S-100 protein and were associated with an accumulation of Type IV collagen, suggesting Schwann cell origin. Electron microscopy revealed numerous fine caliber axons ensheathed by the presumptive Schwann cells, with myelination of individual axonal segments. These findings suggest that chronic i.c.v. delivery of rhNGF has stimulated axonal sprouting and secondary hyperplasia of Schwann or Schwann-like support cells within the pia-arachnoid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184106     DOI: 10.1006/exnr.1997.6448

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  17 in total

1.  Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Drug Deliv Transl Res       Date:  2012-06-01       Impact factor: 4.617

2.  Nerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviors.

Authors:  J Winkler; G A Ramirez; L J Thal; J J Waite
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

Review 3.  Drug transport across the blood-brain barrier.

Authors:  William M Pardridge
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-29       Impact factor: 6.200

4.  Meninges: from protective membrane to stem cell niche.

Authors:  Ilaria Decimo; Guido Fumagalli; Valeria Berton; Mauro Krampera; Francesco Bifari
Journal:  Am J Stem Cells       Date:  2012-05-28

5.  Gene transfer provides a practical means for safe, long-term, targeted delivery of biologically active neurotrophic factor proteins for neurodegenerative diseases.

Authors:  Christopher D Herzog; Kathie M Bishop; Lamar Brown; Alistair Wilson; Jeffrey H Kordower; Raymond T Bartus
Journal:  Drug Deliv Transl Res       Date:  2011-10       Impact factor: 4.617

6.  Treatment of spinal cord injury with co-grafts of genetically modified Schwann cells and fetal spinal cord cell suspension in the rat.

Authors:  Shi-Qing Feng; Xiao-Hong Kong; Shi-Fu Guo; Pei Wang; Li Li; Jin-Hua Zhong; Xin-Fu Zhou
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

7.  Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons.

Authors:  Kathie M Bishop; Eva K Hofer; Arpesh Mehta; Anthony Ramirez; Liangwu Sun; Mark Tuszynski; Raymond T Bartus
Journal:  Exp Neurol       Date:  2008-03-19       Impact factor: 5.330

8.  Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss.

Authors:  Omar Akil; Bas Blits; Lawrence R Lustig; Patricia A Leake
Journal:  Hum Gene Ther       Date:  2018-09-05       Impact factor: 5.695

9.  Nestin- and doublecortin-positive cells reside in adult spinal cord meninges and participate in injury-induced parenchymal reaction.

Authors:  Ilaria Decimo; Francesco Bifari; Francisco Javier Rodriguez; Giorgio Malpeli; Sissi Dolci; Valentina Lavarini; Silvia Pretto; Sandra Vasquez; Marina Sciancalepore; Alberto Montalbano; Valeria Berton; Mauro Krampera; Guido Fumagalli
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

10.  Drug transport in brain via the cerebrospinal fluid.

Authors:  William M Pardridge
Journal:  Fluids Barriers CNS       Date:  2011-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.